ICL Group Ltd. Initial Statement of Beneficial Ownership

ICL Group Ltd. executive Desikan Anantha reported existing stock option holdings in a Form 3.

Accepted by SEC EDGAR 03/30/2026 - 06:26 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ICL Group Ltd. executive Desikan Anantha reported existing stock option holdings in a Form 3. He holds stock options over 545,365 Ordinary Shares at an exercise price of $9.93 per share, fully vested and exercisable, expiring on February 8, 2027.

He also holds stock options over 940,285 Ordinary Shares at an exercise price of $6.03 per share, vesting in three equal annual installments from the April 4, 2024 grant date and expiring on April 4, 2029. The options are held by a Trustee in his name.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Desikan Anantha

Role EVP, Chief Innov. & Tech Ofcr.

Type	Security	Shares	Price	Value
Holding	Stock Options (Right to Buy)	--	--	--
Holding	Stock Options (Right to Buy)	--	--	--

Holdings: Stock Options (Right to Buy) — 1,485,650 contracts (Direct)

Footnotes (5)

1. F1. The stock options are fully vested and exercisable.
2. F2. The stock options vest in three equal annual installments from the April 4, 2024 grant date.
3. F3. Represents an exercise price of NIS 31.27, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.
4. F4. The options are held by a Trustee in the name of the Reporting Person.
5. F5. Represents an exercise price of NIS 18.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

Key Figures

Fully vested options: 545,365 underlying shares at $9.93 Partially vesting options: 940,285 underlying shares at $6.03 Total underlying shares: 1,485,650 shares +2 more

5 metrics

Fully vested options 545,365 underlying shares at $9.93 Stock Options (Right to Buy), expiration February 8, 2027

Partially vesting options 940,285 underlying shares at $6.03 Vest in three annual installments from April 4, 2024; expire April 4, 2029

Total underlying shares 1,485,650 shares Combined underlying Ordinary Shares for both option grants

NIS 31.27 option price $9.93 equivalent Converted using $1.00 = NIS 3.149 as of March 27, 2026

NIS 18.99 option price $6.03 equivalent Converted using $1.00 = NIS 3.149 as of March 27, 2026

Key Terms

Stock Options (Right to Buy), Ordinary Shares, vest in three equal annual installments, Bank of Israel representative exchange rate, +1 more

5 terms

Stock Options (Right to Buy) financial

"security_title: Stock Options (Right to Buy)"

Ordinary Shares financial

"underlying_security_title: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

vest in three equal annual installments financial

"The stock options vest in three equal annual installments from the April 4, 2024 grant date."

Bank of Israel representative exchange rate financial

"converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149"

Trustee financial

"The options are held by a Trustee in the name of the Reporting Person."

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Desikan Anantha

(Last) (First) (Middle)

C/O ICL GROUP LTD.

MILLENNIUM TOWER, 23 ARENHA ST.

(Street)

TEL AVIV 6120201

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ICL Group Ltd. [ ICL ]

3a. Foreign Trading Symbol
[ICL]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Innov. & Tech Ofcr.

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	(1)	02/08/2027	Ordinary Shares	545,365	$9.93(3)	D(4)
Stock Options (Right to Buy)	(2)	04/04/2029	Ordinary Shares	940,285	$6.03(5)	D(4)

Explanation of Responses:

1. The stock options are fully vested and exercisable.

2. The stock options vest in three equal annual installments from the April 4, 2024 grant date.

3. Represents an exercise price of NIS 31.27, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

4. The options are held by a Trustee in the name of the Reporting Person.

5. Represents an exercise price of NIS 18.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

	/s/ Desikan Anantha	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)